4th April 2021
Paula, who is being treated by The Clatterbridge Cancer Centre, has become one of the first people in England to benefit from a new 5-minute breast cancer treatment being rolled out across the NHS. Phesgo combines trastuzumab and pertuzumab into a single injection for HER2-positive breast cancers.